Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Minerva Surgical, Inc. logo — We are the best in class Uterine Health Company for the trea...

Minerva Surgical, Inc.

We are the best in class Uterine Health Company for the treatment of Abnormal Uterine Bleeding (AUB).

Founded 2008 United States Santa Clara, United States 135 employees Post Ipo Equity Total: $173.88M Health Care, Manufacturing +2

General Information

Company Name Minerva Surgical, Inc.
Founded Year 2008
Location United States Santa Clara, United States +1
Founders / Decision Makers
Team member
Employees 135
Industries Health Care, Manufacturing, Medical Devices +1
Funding Stage Post Ipo Equity
Social

Get notified when Minerva Surgical, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Minerva Surgical, Inc.

Minerva Surgical, Inc. is a leader in uterine health, specializing in the treatment of Abnormal Uterine Bleeding (AUB). Founded in 2008 and headquartered in the United States, Minerva offers a comprehensive suite of devices designed to address the root causes of AUB. Their relentless focus on minimally invasive intrauterine treatments has positioned them at the forefront of gynecologic surgery advancements. In 2015, Minerva introduced a groundbreaking product that revolutionized the treatment of AUB. Their commitment to women's uterine wellness and the development of AUB treatment technologies is unwavering. The company recently received a significant $30.00M post-IPO equity investment on 27 December 2022, with backing from prominent firms such as New Enterprise Associates and Accelmed Partners. Minerva's impact on the healthcare and manufacturing industries is substantial, making it an attractive prospect for investors seeking opportunities in the burgeoning field of women's health. With a robust product portfolio and strong investor support, Minerva Surgical, Inc. is well-positioned for continued growth and innovation in the years to come. For more information, visit their website at https://minervasurgical.com and explore their contributions to advancing women's healthcare.

Taxonomy: Uterine Health, Abnormal Uterine Bleeding, Minimally Invasive Treatments, Gynecologic Surgery, Women's Health, OBGYN, Endometrial Ablation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 2
Investor Investor
27 Dec 2022
Debt Financing •••••• - 06 Dec 2019
Debt Financing •••••• 1
Investor
01 Jan 2019
Venture Round •••••• 1 •••• •••• 29 Dec 2016
Venture Round •••••• 1 •••• •••• 23 Sep 2014

View All 8 Funding Rounds

Minerva Surgical, Inc. Alternatives & Competitors

Minerva Surgical, Inc. vs
OCON Therapeutics
OCON Therapeutics Israel

We revolutionize women's quality of life and freedom of choice with healthier, safer uterine drug-de...

Series A
30 employees
Health Care, Pharmaceutical
Compare Minerva Surgical, Inc. vs OCON Therapeutics
Minerva Surgical, Inc. vs
Avana Health
Avana Health

A women's health company developing novel treatments for postpartum hemorrhage and abnormal uterine...

Seed
9 employees
Health Care, Life Sciences
Compare Minerva Surgical, Inc. vs Avana Health
Minerva Surgical, Inc. vs
Impres Medical
Impres Medical

Crafting state-of-the-art solutions for minimally invasive treatments of uterine bleeding since 1999...

Debt Financing
Health Care
Compare Minerva Surgical, Inc. vs Impres Medical

FAQ About Minerva Surgical, Inc.

We are the best in class Uterine Health Company for the treatment of Abnormal Uterine Bleeding (AUB).
Minerva Surgical, Inc. was founded in 2008.
Minerva Surgical, Inc. is headquartered in Santa Clara, United States.
Minerva Surgical, Inc. operates in the following industries: Health Care, Manufacturing, Medical Devices, Women's Health.
Minerva Surgical, Inc. has approximately 135 employees.
Minerva Surgical, Inc. has completed 8 funding rounds, raising a total of $173.88M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Minerva Surgical, Inc. include OCON Therapeutics, Avana Health, Impres Medical, Neurocrine Biosciences, Central Adelaide. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Minerva Surgical, Inc. and OCON Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Minerva Surgical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes